coteauBeta Get App

DGX

Quest Diagnostics
$241.89
-0.57% Oct 23 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-5%+6%+17%+28%+38%Oct 2025Oct 2026Apr 202652w high $246.5352w low $170.62
DGXSPY
1W
+2.9%
1M
+4.2%
3M
+6.6%
6M
+24.2%
YTD
+41.7%
1Y
+34.2%

Live chart

Loading live chart…

What they do

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians.

Healthcare · Diagnostics & Research

For information only · Important disclosures

Grades vs sector

Momentum
69th percentile in sector
B
12-1 return: +34.2%
Percentile within its GICS sector across the S&P 1500.
Growth
60th percentile in sector
B-
Revenue growth (YoY): +10.2%
Percentile within its GICS sector across the S&P 1500.
Value
52nd percentile in sector
C+
Forward E/P: 5.1% · EBITDA/EV: 7.1%
Percentile within its GICS sector across the S&P 1500.
Profitability
58th percentile in sector
B-
Profit margin: +9.2% · Return on equity: +14.6%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 145 of 499 · 12-month momentum 28.3%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 Coteau Long Book
Not in the current book

News

More news
Western Digital's Q1 Earnings & Revenues Beat, Dividend Hiked by 17%
Zacks · 14h ago
Quest Diagnostics: 3 Key Takeaways for Long-Term Investors
Nasdaq · Oct 22
Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript
Nasdaq · Oct 22
Quest Diagnostics Q3 26 Earnings Conference Call At 8:30 AM ET
Nasdaq · Oct 22
Quest Diagnostics (DGX) files 8-K: other event
SEC 8-K · Oct 22

Key stats

52-week range$170.62 – $246.53
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

Earnings

Next report: –
No EPS history available.
Insider trades
Davis J. E.
Director, CEO and President · 2026-09-01
Sell
$2.4M
Prevoznik Michael E
SVP & General Counsel · 2026-08-28
Sell
$105.1K
Prevoznik Michael E
SVP & General Counsel · 2026-08-28
Sell
$1.5M
Prevoznik Michael E
SVP & General Counsel · 2026-08-28
Sell
$3.9M
Delaney Mark E
SVP & Chief Commercial Officer · 2026-07-28
Sell
$376.3K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed – ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Free to use. No card, no ads, no auto-renew.

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Beta 0.9 · Oct 21, 2026